STOCK TITAN

Kura Oncology officer proposes $148K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Kura Oncology, Inc. (KURA) lists a Form 144 notice by officer Mollie Leoni for a proposed sale of 19,009 common shares, with an aggregate market value of $147,699.93 and an approximate sale date of November 16, 2026. The shares are listed as acquired from the issuer through a PSU transaction on November 13, 2026.

During the preceding three months, the notice lists a sell-to-cover sale of 12,448 performance-based restricted stock units on September 28, 2026, for gross proceeds of $130,670.39, and 28,802 units in an entry labeled 10b5-1 Sales on September 29, 2026, for gross proceeds of $309,565.84. The listed number of common shares outstanding is 92,784,785. Teresa Bair signed as attorney-in-fact for Mollie Leoni.

Proposed common shares for sale 19,009 shares Approximate sale date November 16, 2026
Aggregate market value $147,699.93 Proposed sale of 19,009 common shares
Common shares outstanding 92,784,785 shares As listed in the notice
September 28 sell-to-cover sale 12,448 performance-based restricted stock units Gross proceeds of $130,670.39 on September 28, 2026
September 28 gross proceeds $130,670.39 Sell-to-cover sale on September 28, 2026
September 29 sale labeled 10b5-1 Sales 28,802 performance-based restricted stock units Gross proceeds of $309,565.84 on September 29, 2026
September 29 gross proceeds $309,565.84 Entry labeled 10b5-1 Sales on September 29, 2026
Performance-Based Restricted Stock Units financial
"Title of securities sold: Performance-Based Restricted Stock Units"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
sell-to-cover financial
"Sell-to-cover for Mollie Leoni"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
10b5-1 Sales regulatory
"10b5-1 Sales for Mollie Leoni"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KURA shares did Mollie Leoni report for sale?

Officer Mollie Leoni reported a proposed sale of 19,009 Kura common shares, with an aggregate market value of $147,699.93 and an approximate sale date of November 16, 2026.

What prior KURA stock sales did Mollie Leoni report?

The notice lists a sell-to-cover sale of 12,448 performance-based restricted stock units on September 28, 2026, for gross proceeds of $130,670.39, and an entry labeled 10b5-1 Sales for 28,802 units on September 29, 2026, for gross proceeds of $309,565.84.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading